Oventus is an Australian medical device company and is listed on the Australian Securities Exchange (ASX: OVN). We offer a new treatment modality for obstructive sleep apnoea (OSA) via our Airway Technology. We are committed to providing the highest quality corporate governance and the generation of sustainable, long-term returns for our shareholders. Our mission is to be a global leader in the treatment of snoring and OSA. What makes us unique is our patented airway design, allowing for breathing through our O2VentTM oral devices to bypass obstructions of the nose, soft palate and tongue that can contribute to snoring and OSA. The O2VentTM is bridging the gap between Oral Appliance and CPAP therapy to enhance treatment outcomes, including for CPAP intolerant sleep apnoea sufferers.
07/08/2020 17:27:00
To view the Notification of issue, conversion or payment up of equity
+securities, download the attached PDF.
Interviews /
by Rachael Jones -
5 years ago
18 Dec 2019 - Oventus Medical Limited (ASX:OVN) Managing Director and CEO, Dr Chris Hart talks about the company's North American sales process via its lab in lab model and how thi…
Interviews /
by Jessica Amir -
5 years ago
26 Jun 2019 - Oventus Medical Limited (ASX:OVN) Managing Director & CEO Dr Chris Hart discusses the company's sleep apnoea treatment platform Canadian sales agreements.
Interviews /
by Jessica Amir -
5 years ago
22 May 2019 - Oventus Medical Limited (ASX:OVN) Vice President of Marketing and Operations Robin Randolph talks North America progress and the company's expansion into Australia an…
Market Reports /
by Rachael Jones -
6 years ago
08 Jan 2019 - The ASX started to work its way up from 11:00am this morning and is now tracking 0.4% higher at noon. Telco services performed well, but consumer staples saw a small …
Company Presentations /
by -
6 years ago
17 Oct 2018 - Oventus Medical Limited (ASX:OVN) founder, Managing Director and CEO, Dr Chris Hart talks the company's sales push into the US, new product development and changes in…
Interviews /
by Rachael Jones -
6 years ago
17 Oct 2018 - Oventus Medical Limited (ASX:OVN) founder, Managing Director and CEO, Dr Chris Hart discusses the company's sales push into the US, new product development and change…
Interviews /
by Carolyn Herbert -
7 years ago
17 Aug 2017 - Oventus Medical Limited (ASX:OVN) Founder and Clinical Director Dr Chris Hart discusses FDA clearance for the company's O2 Vent W model and its agreement with leading…
Market Reports /
by Carolyn Herbert -
7 years ago
12 Jul 2017 - In the red: Aus shares 0.78% lower at noon. Oventus Medical Limited (ASX:OVN) says it has received FDA 510k clearance for its O2 Vent W – winged or dorsal flex oral …
Market Reports /
by Clive Tompkins -
7 years ago
22 Jun 2017 - It has been a positive end to the trading session for the Australian share market today, with the market building on its positive start, closing 0.7 per cent higher. …
Market Reports /
by Jessica Amir -
7 years ago
20 Jun 2017 - Defying positive overseas leads: Aus shares 0.39% lower at noon. Slater and Gordon Limited (ASX:SGH) advises that a class action has been served on it by Babscay Limi…
Market Reports /
by Carolyn Herbert -
7 years ago
03 May 2017 - Pulling back: Aus shares close 0.98% lower. Oventus Medical Limited (ASX:OVN) has announced significant progress relating to clinical validation of its O2 Vent oral …
Company News /
by Jessica Amir -
8 years ago
2 Feb 2017 - Oventus Medical Limited (ASX:OVN) announces it is recalling its product, O2Vent T, which is an oral device used to help snorers and people with obstructive sleep apnea…
Interviews /
by Carolyn Herbert -
8 years ago
07 Nov 2016 - Oventus Medical Limited (ASX:OVN) Founder and Clinical Director Dr Chris Hart discusses the company’s sleep apnoea product O2 Vent.
Market Reports /
by Carolyn Herbert -
8 years ago
26 09 2016 - In the red: ASX200 down 0.22% at noon. Oventus Medical Limited (ASX:OVN) says it has received clearance from the US FDA for its O2Vent device.
Interviews /
by David Chau -
8 years ago
22 Jul 2016 - Oventus Medical Limited (ASX:OVN) Founder & Executive Director, Dr Chris Hart, discusses the company’s sleep apnoea produ…
